Ads
related to: bruton's tyrosine kinase- Dosing & Administration
BTK Inhibitor Dosing
And Administration Info
- Product Overview
Learn About A BTK Inhibitor
View Product Information
- HCP Resources
Downloadable Material
Available For Physicians
- Safety Profile
View Important Safety Info
For A BTK Inhibitor
- Dosing & Administration
Search results
AstraZeneca reports positive interim data from mantle cell lymphoma trial
Clinical Trials Arena via Yahoo Finance· 4 weeks agoAstraZeneca has announced positive interim results from the Phase III ECHO clinical trial, which...
FDA Approves BeiGene's Brukinsa For Chronic Lymphocytic Leukemia
Benzinga via Yahoo Finance· 1 year agoThe FDA has approved BeiGene Ltd's (NASDAQ: BGNE) Bruton's tyrosine kinase inhibitor (BTKi) Brukinsa...
Oncternal (ONCT) Down on Restructuring Plan to Extend Runway
Zacks via Yahoo Finance· 1 year agoShares of clinical-stage biopharmaceutical company Oncternal Therapeutics, Inc. ONCT plunged 59.3%...
Roche's (RHHBY) MS Drug Meets Goals in the Phase II Study
Zacks via Yahoo Finance· 1 year agoRoche RHHBY announced that the mid-study evaluating investigational oral fenebrutinib in adults with...
Oncternal Therapeutics Announces Strategic Reprioritization, Stops Two Zilovertamab Studies
Benzinga via Yahoo Finance· 1 year agoOncternal Therapeutics Inc (NASDAQ: ONCT) will suspend Phase 3 and the Phase 1/2 studies of...
U.S. pauses new patients on Merck MS drug in blow to shares
Reuters via Yahoo News· 1 year agoBERLIN (Reuters) -Merck KGaA said on Wednesday the U.S. Food and Drug Administration (FDA) had...
Merck KGaA suffers major blow as MS drug fails in late-stage trials
Reuters via Yahoo News· 6 months agoFRANKFURT (Reuters) -Merck KGaA's experimental multiple sclerosis (MS) drug missed the primary goal...
AbbVie's Imbruvica Scores First Approval For Pediatric Patients After Bone Marrow Transplant
Benzinga via Yahoo Finance· 2 years agoThe FDA approved AbbVie Inc's (NYSE: ABBV) Imbruvica (ibrutinib) for pediatric patients one year and...
Glenmark to market BeiGene’s oncology medicines in India
Pharmaceutical Technology via Yahoo Finance· 1 week agoGlenmark Pharmaceuticals subsidiary Glenmark Specialty has entered an exclusive agreement to market...
German Merck’s MS drug falls short in pair of Phase 3 tests
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: An emerging class of drugs under development to treat multiple sclerosis suffered...
